Welcome to Rebound, a Mobile Medical Care Unit! That’s right – we come to you in our state-of-the-art Community Mobile Medical Vehicle!

We focus on providing Vivitrol injections on-site, at your location. Vivitrol is a once-per-month FDA approved injectable medication that has proven key in the fight against addiction. Unfortunately, large numbers of eligible patients are not being offered this potentially life-saving medication.

Why a Vivitrol Injector Program?

Addiction has become one of the greatest public health epidemics in recent history. (Please refer to Appendix 1 for statistics about addiction)

Relapse is the rule. While the medical community has gained knowledge about addiction in the last couple of decades, medications to treat this onerous disease have been limited in their efficacy and availability.

Vivitrol, an FDA-approved anti-addiction medication, blocks the opioid receptor in the brain, and has proven to be a key clinical tool not only in the fight against opiate addiction (including both prescription painkillers and heroin) but also against alcohol addiction.

Patients with opiate addiction who receive a Vivitrol injection cannot experience “getting high” for 28 days and report significant reductions in cravings for opiates. Alcoholic patients who receive a Vivitrol injection experience significant reductions in cravings for alcohol and are less likely to drink heavily if they relapse.

Why Rebound and our Mobile Vivitrol Injector Program?

We developed a Mobile Vivitrol Injector Program under the direction of Addiction Psychiatrist Scott Bienenfeld, M.D., who is certified by The American Board of Addiction Medicine (ABAM). We eliminate the hassles of Medicaid and Commercial Insurance pre-certifications and prior authorizations. We take care of the whole process so that patients can receive a Vivitrol injection every 28 days, even on short notice, on-site at your location. We help you to reach the scores of patients who could benefit, but are not receiving treatment.

We require that patients who receive a Vivitrol injection remain in treatment with their referring treaters. We ensure that all patients receive regular follow-up and that they receive Vivitrol injections every 28 days. We also take care of monitoring blood work.

Being fully mobile allows Rebound to provide Vivitrol injections “on-site,” with the capacity to reach the large numbers of patients requiring treatment.

Not only do we make it safe and easy for patients to receive Vivitrol injections, we also provide direct follow-up and communication with each agency to ensure that clinical care is coordinated. For many patients, getting the Vivitrol injection quickly can mean the difference between abstinence and relapse – for some, life and death.

Scott Bienenfeld, M.D.

Important Information About Opioid Use Disorder & Alcohol

From ASAM.org

Opioid Use Disorder

Opioids are a class of drugs that include the illicit drug heroin as well as the licit prescription pain relievers oxycodone, hydrocodone, codeine, morphine, fentanyl and others.

Opioids are chemically related and interact with opioid receptors on nerve cells in the brain and nervous system to produce pleasurable effects and relieve pain.

Addiction is a primary, chronic and relapsing brain disease characterized by an individual pathologically pursuing reward and/or relief by substance use and other behaviors.

Of the 21.5 million Americans 12 or older that had a substance use disorder in 2014, 1.9 million had a substance use disorder involving prescription pain relievers and 586,000 had a substance use disorder involving heroin.

It is estimated that 23% of individuals who use heroin develop opioid addiction. National Opioid Overdose Epidemic.

Drug overdose is the leading cause of accidental death in the US, with 47,055 lethal drug overdoses in 2014. Opioid addiction is driving this epidemic, with 18,893 overdose deaths related to prescription pain relievers, and 10,574 overdose deaths related to heroin in 2014.

From 1999 to 2008, overdose death rates, sales and substance use disorder treatment admissions related to prescription pain relievers increased in parallel. The overdose death rate in 2008 was nearly four times the 1999 rate; sales of prescription pain relievers in 2010 were four times those in 1999; and the substance use disorder treatment admission rate in 2009 was six times the 1999 rate.

In 2012, 259 million prescriptions were written for opioids, which is more than enough to give every American adult their own bottle of pills.

Four in five new heroin users started out misusing prescription painkillers.
94% of respondents in a 2014 survey of people in treatment for opioid addiction said they chose to use heroin because prescription opioids were “far more expensive and harder to obtain.”

From: www.niaaa.hih.gov

Alcohol Facts and Statistics

Alcohol Use in the United States:

Prevalence of Drinking: In 2014, 87.6 percent of people ages 18 or older reported that they drank alcohol at some point in their lifetime; 71.0 percent reported that they drank in the past year; 56.9 percent reported that they drank in the past month.

Prevalence of Binge Drinking and Heavy Drinking: In 2014, 24.7 percent of people ages 18 or older reported that they engaged in binge drinking in the past month; 6.7 percent reported that they engaged in heavy drinking in the past month.

Alcohol Use Disorder (AUD) in the United States:

Adults (ages 18+): 16.3 million adults ages 18 and older3 (6.8 percent of this age group4) had an AUD in 2014. This includes 10.6 million men3 (9.2 percent of men in this age group4) and 5.7 million women3 (4.6 percent of women in this age group).

About 1.5 million adults received treatment for an AUD at a specialized facility in 2014 (8.9 percent of adults who needed treatment)5. This included 1.1 million men (9.8 percent of men in need) and 431,000 women (7.4 percent of women who needed treatment)

Youth (ages 12–17): In 2014, an estimated 679,000 adolescents ages 12–176 (2.7 percent of this age group7) had an AUD. This number includes 367,000 females6 (3.0 percent of females in this age group7) and 311,000 males6 (2.5 percent of males in this age group).

An estimated 55,000 adolescents (18,000 males and 37,000 females) received treatment for an alcohol problem in a specialized facility in 2014.

Alcohol-Related Deaths:

Nearly 88,0009 people (approximately 62,000 men and 26,000 women9) die from alcohol-related causes annually, making alcohol the fourth leading preventable cause of death in the United States.

In 2014, alcohol-impaired driving fatalities accounted for 9,967 deaths (31 percent of overall driving fatalities).

Economic Burden:

In 2010, alcohol misuse problems cost the United States $249.0 billion.12
Three-quarters of the total cost of alcohol misuse is related to binge drinking.

Global Burden:

In 2012, 3.3 million deaths, or 5.9 percent of all global deaths (7.6 percent for men and 4.0 percent for women), were attributable to alcohol consumption.

Alcohol contributes to over 200 diseases and injury-related health conditions, most notably alcohol dependence, liver cirrhosis, cancers, and injuries.14 In 2012, 5.1 percent of the burden of disease and injury worldwide (139 million disability-adjusted life-years) was attributable to alcohol consumption.

Globally, alcohol misuse is the fifth leading risk factor for premature death and disability; among people between the ages of 15 and 49, it is the first.15 In the age group 20–39 years, approximately 25 percent of the total deaths are alcohol attributable.

We look forward to talking.
REBOUND NY Contact Form
Thanks for reaching out. We look forward to getting to know you and your patients.